Sinemet Cr
Sinemet Cr is a neurology medication containing Carbidopa + Levodopa, available as 25/100mg tablets.
Details
- Conditions
- Parkinson's disease
- Alternative Name
- Sinemet, Caramet, Duodopa
- Therapeutic Class
- Dopamine Precursor / Dopa Decarboxylase Inhibitor
- Pharmacological Class
- Dopaminergic Agent
- Minor Side Effects
- nausea, dizziness, dry mouth
- Moderate Side Effects
- involuntary movements, confusion, orthostatic hypotension
- Dosage Forms
- Modified-release tablet
- Administration Route
- Oral use
- Prescription Status
- Available without prescription
- Manufacturer
- MSD
- Onset Time
- 30–90 minutes
- Duration
- 4–6 hours
- Storage Instructions
- Store below 25°C, keep container closed.
- Drug Interactions
- iron supplements, antipsychotics
- Age Restrictions
- Not recommended for children.